Adagene (ADAG) Operating Leases (2022 - 2026)
Adagene (ADAG) posted quarterly Operating Leases of $53.5 billion for Q4 2025, down 62.42% year-over-year from $142.3 billion in Q4 2024, and up 60289624.37% quarter-over-quarter from $88705.0 in Q2 2025.
Adagene (ADAG) Operating Leases (2022 - 2026) Analysis & Trends
Adagene (ADAG) has reported Operating Leases for 4 consecutive years, with $53.5 billion the latest figure, recorded in Q4 2025.
- In Q4 2025, Operating Leases fell 62.42% year-over-year to $53.5 billion; the TTM figure through Dec 2025 stood at $53.5 billion (down 62.42% YoY), while the FY2025 annual figure was $53.5 billion, down 62.42% from the prior year.
- Operating Leases grew to $53.5 billion in Q4 2025 per ADAG's latest filing, from $88705.0 in the prior quarter.
- Across five years, Operating Leases topped out at $173.7 billion in Q4 2023 and bottomed at $88705.0 in Q2 2025.
- Historically, Operating Leases has averaged $86.6 billion across 4 years, with a median of $91.0 billion in 2022.
- Annual changes were most pronounced in 2023 — Operating Leases surged 222.58% — and 2024, when it sank 100.0%.
- Adagene's Operating Leases stood at $53.8 billion in 2022, then soared by 222.58% to $173.7 billion in 2023, then fell by 18.06% to $142.3 billion in 2024, then slumped by 62.42% to $53.5 billion in 2025.
- Business Quant data shows ADAG's Operating Leases at $53.5 billion in Q4 2025, $88705.0 in Q2 2025, and $142.3 billion in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Adagene | 310.54 Mn | 310.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 183,189.00 |
| Dec 31, 2025 | 53.48 Bn |
| Jun 30, 2025 | 88,705.00 |
| Dec 31, 2024 | 142.30 Bn |
| Jun 30, 2024 | 114,086.00 |
| Dec 31, 2023 | 173.66 Bn |
| Jun 30, 2023 | 141.43 Bn |
| Dec 31, 2022 | 53.83 Bn |
| Jun 30, 2022 | 128.08 Bn |